JPH0237882B2 - CHIKUSANDOBUTSUNODENSENSEISHITSUKANNOYOKUSEIHOHO - Google Patents
CHIKUSANDOBUTSUNODENSENSEISHITSUKANNOYOKUSEIHOHOInfo
- Publication number
- JPH0237882B2 JPH0237882B2 JP21063182A JP21063182A JPH0237882B2 JP H0237882 B2 JPH0237882 B2 JP H0237882B2 JP 21063182 A JP21063182 A JP 21063182A JP 21063182 A JP21063182 A JP 21063182A JP H0237882 B2 JPH0237882 B2 JP H0237882B2
- Authority
- JP
- Japan
- Prior art keywords
- minutes
- formula
- solution
- compound
- hydrochloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241000287828 Gallus gallus Species 0.000 claims description 21
- 244000144972 livestock Species 0.000 claims description 11
- 241001465754 Metazoa Species 0.000 claims description 10
- 229940079593 drug Drugs 0.000 claims description 9
- 239000003814 drug Substances 0.000 claims description 9
- 238000005507 spraying Methods 0.000 claims description 9
- -1 polyhexamethylene Polymers 0.000 claims description 8
- 208000035473 Communicable disease Diseases 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- 244000144977 poultry Species 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 2
- 238000006116 polymerization reaction Methods 0.000 claims description 2
- 239000000243 solution Substances 0.000 description 32
- 150000001875 compounds Chemical class 0.000 description 31
- 239000000645 desinfectant Substances 0.000 description 29
- 230000000844 anti-bacterial effect Effects 0.000 description 23
- 230000001580 bacterial effect Effects 0.000 description 21
- 238000010790 dilution Methods 0.000 description 21
- 239000012895 dilution Substances 0.000 description 21
- 235000013330 chicken meat Nutrition 0.000 description 20
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 19
- 241000894006 Bacteria Species 0.000 description 17
- 241000282887 Suidae Species 0.000 description 15
- 241000187480 Mycobacterium smegmatis Species 0.000 description 14
- 210000003608 fece Anatomy 0.000 description 14
- 206010070834 Sensitisation Diseases 0.000 description 13
- 230000008313 sensitization Effects 0.000 description 13
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 12
- 229960000686 benzalkonium chloride Drugs 0.000 description 12
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 12
- 229930003836 cresol Natural products 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 239000010871 livestock manure Substances 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 10
- 241000193738 Bacillus anthracis Species 0.000 description 9
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 9
- 241000607142 Salmonella Species 0.000 description 9
- 241000588724 Escherichia coli Species 0.000 description 8
- 239000012153 distilled water Substances 0.000 description 8
- 230000001717 pathogenic effect Effects 0.000 description 8
- 235000002639 sodium chloride Nutrition 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 239000007788 liquid Substances 0.000 description 7
- 239000000344 soap Substances 0.000 description 7
- 238000004659 sterilization and disinfection Methods 0.000 description 7
- 210000002216 heart Anatomy 0.000 description 6
- 230000003902 lesion Effects 0.000 description 6
- 239000008149 soap solution Substances 0.000 description 6
- 241000283690 Bos taurus Species 0.000 description 5
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000001802 infusion Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 238000009395 breeding Methods 0.000 description 4
- 230000001488 breeding effect Effects 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 210000001165 lymph node Anatomy 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 235000013594 poultry meat Nutrition 0.000 description 4
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 3
- 229940065181 bacillus anthracis Drugs 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 230000000249 desinfective effect Effects 0.000 description 3
- 208000027531 mycobacterial infectious disease Diseases 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 201000008827 tuberculosis Diseases 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- 244000026610 Cynodon dactylon var. affinis Species 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241000204031 Mycoplasma Species 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 208000022338 anthrax infection Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- OKJPEAGHQZHRQV-UHFFFAOYSA-N iodoform Chemical compound IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 2
- FDZZZRQASAIRJF-UHFFFAOYSA-M malachite green Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1C(C=1C=CC=CC=1)=C1C=CC(=[N+](C)C)C=C1 FDZZZRQASAIRJF-UHFFFAOYSA-M 0.000 description 2
- 229940107698 malachite green Drugs 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000005416 organic matter Substances 0.000 description 2
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000011120 plywood Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000013207 serial dilution Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 229960001005 tuberculin Drugs 0.000 description 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000606767 Avibacterium paragallinarum Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000193155 Clostridium botulinum Species 0.000 description 1
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical class [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000606790 Haemophilus Species 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- 206010062207 Mycobacterial infection Diseases 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- 241000186364 Mycobacterium intracellulare Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- GLMQHZPGHAPYIO-UHFFFAOYSA-L azanium;2-hydroxypropane-1,2,3-tricarboxylate;iron(2+) Chemical compound [NH4+].[Fe+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O GLMQHZPGHAPYIO-UHFFFAOYSA-L 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 150000002497 iodine compounds Chemical class 0.000 description 1
- 235000000011 iron ammonium citrate Nutrition 0.000 description 1
- 239000004313 iron ammonium citrate Substances 0.000 description 1
- 150000003893 lactate salts Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004880 lymph fluid Anatomy 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 150000002688 maleic acid derivatives Chemical class 0.000 description 1
- 150000002690 malonic acid derivatives Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical group [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 210000000713 mesentery Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- QYSGYZVSCZSLHT-UHFFFAOYSA-N octafluoropropane Chemical compound FC(F)(F)C(F)(F)C(F)(F)F QYSGYZVSCZSLHT-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- SSOLNOMRVKKSON-UHFFFAOYSA-N proguanil Chemical compound CC(C)\N=C(/N)N=C(N)NC1=CC=C(Cl)C=C1 SSOLNOMRVKKSON-UHFFFAOYSA-N 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 150000003890 succinate salts Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 150000003892 tartrate salts Chemical class 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- YFYABWXIJBTAAM-UHFFFAOYSA-M trimethyl(2-phenyltetradecan-2-yl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCC(C)([N+](C)(C)C)C1=CC=CC=C1 YFYABWXIJBTAAM-UHFFFAOYSA-M 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
本発明は畜産動物の伝染性疾患の抑制方法に関
する。
最近各地で豚の抗酸菌性が集団的に多発し、公
衆衛生上から問題にされている。豚の抗酸菌症の
原因菌はミコバクテリウム・スメグマテイス、ミ
コバクテリウム・イントラセルラーレなどの非定
型抗酸菌であり、この菌に感染すると結核類似の
病巣を形成し、いわゆる非定型抗酸菌症となる。
非定型抗酸菌症は病状が緩慢なために一般臨床症
状では異常が認め難く、発育がやや悪いという程
度であり、屠畜場検査ではじめて発見されるのが
ほとんどである。そして本病の病巣は、一般に頭
頚部、腸間膜のリンパ節に局限され、直径数ミリ
の帯黄灰白色の乾酪巣から、リンパ節全体が腫大
しているものなど様々である。この疾患の予防及
び治療に有効なワクチンや薬剤は知られていな
い。したがつてツベルクリン反応でできるだけ早
く感染豚を発見し、他の豚から隔離すると共に、
豚舎をよく清掃水洗したのち消毒を行うしか対策
がない。しかしいかなる殺菌剤を使用しても完全
に殺菌消毒することはできないとされている。
本発明者らはポリヘキサメチレンバイガナジン
又はその塩が、この疾患の原因菌であるミコバク
テリウム・スメグマテイスやミコバクテリウム・
イントラセルラーレに対し優れた殺菌作用を有
し、他の消毒剤と異なり、例えば鶏糞などの有機
物の存在下でも強い殺菌力を保持することを見出
した。
さらにニワトリにおいても例えばヒナ白痢、呼
吸器病、大腸菌症などが集団的に多発する。これ
らの伝染性疾患の原因菌はサルモネラ・プロラ
ム、サルモネラ・テイフイミリウム、ヘモフイー
ルス・ガリナーラム、マイコプラズマ・シノビ
エ、病原性大腸菌などである。さらに牛の乳房炎
あるいは豚や鶏の感染症で、菌交代現象による緑
膿菌の定着のため、治癒を遅らせたり、感染症の
発生をみることもある。また近時は牛豚における
炭疸菌による感染症も問題とされている。
本発明者らはこれらについても研究した結果、
前記のポリヘキサメチレンバイガナジン又はその
塩が、前記の菌に10〜15分の感作により2000〜
16000倍の希釈度で殺菌作用を示すこと、ならび
に鶏糞の存在下でも大腸菌などに対する殺菌作用
があまり低下しないことを見出した。そしてこの
化合物による畜鶏舎、器具、器材などの消毒方法
を研究した結果、本発明に到達した。
本発明は、式
(式中nは化合物の分子量が700〜1300に相当す
る重合度を示す数字である)で表わされるポリヘ
キサメチレンバイガナジン又はその塩を含む薬剤
を用い、畜鶏舎及び/又はその器具、器材に対し
て噴霧、散布もしくは洗浄することを特徴とする
畜産動物の伝染性疾患の抑制方法である。
式の化合物は、米国特許第2643232号及び第
3428576号各明細書により公知であつて、一般細
菌に抗菌力を示すことが知られている。また特公
昭55−42611号公報によれば、ボツリヌス菌に有
効なことも知られている。しかしミコバクテリウ
ム・スメグマテイスなどに代表される抗酸菌、サ
ルモネラ・プロラム、サルモネラ・テイフイミリ
ウム、ヘモフイールス・カリナーラム、マイコプ
ラズマ・シノビエ、病原性大腸菌、炭疸菌などに
優れた殺菌作用を示すこと、そして各種の有機物
例えば鶏糞や血液などが存在しても、例えばミコ
バクテリウム・スメグマテイスや病原性大腸菌に
対する殺菌力があまり低下せず、これを用い、噴
霧、散布もしくは洗浄することにより畜産動物の
伝染性疾患を効果的に抑制しうることは、本発明
者らによる新知見である。これに対し他の殺菌剤
例えば塩素、沃素化合物、逆性石鹸などは、ミコ
バクテリウム・スメグマテイスなどに対し、前記
のような有機物の存在により著しく作用が低下
し、ほとんど実効を奏しない。
本発明を実施するに際しては、式の化合物又
はその塩を畜鶏舎及び器具、器材などに噴霧又は
散布もしくはこれによる洗浄を行う。これにより
舎内、糞尿あるいは畜産動物の体表面などの病原
性細菌を殺菌することができる。
式の化合物の分子量は700〜1300、好ましく
は900〜1100である。式の化合物のハロゲン化
水素酸塩、硫酸塩、硝酸塩などの無機酸塩又は乳
酸塩、酒石酸塩、コハク酸塩、マレイン酸塩、マ
ロン酸塩、グルコン酸塩などの有機酸塩は、水及
び有機溶剤に比較的よく溶けるので、溶液の形に
して噴霧、散布又は洗浄に用いることができる。
また溶液の代わりに適当な粉末の希釈剤とともに
微粉にして噴霧又は散布してもよい。式の化合
物又はその塩の溶液もしくは微粉体中の濃度は
0.01〜10重量%、好ましくは0.03〜5重量%であ
る。式の化合物又はその塩の1日当りの使用量
は、例えば豚1頭当り10〜1000mg、好ましくは30
〜800mg、鶏1羽当り1〜100mg、好ましくは3〜
80mg、牛1頭当り0.1〜10g、好ましくは0.3〜8
gである。通常1日1〜10回程度に分けて、畜産
動物の飼育期間中毎日噴霧又は散布もしくはこれ
による洗浄を行う。その場合1回当り30秒〜30分
程度例えば舎内空間に薬剤の微粒子(0.1〜60μ程
度)が滞留しうるようにすることが好ましい。
実験例 1
非定型抗酸菌の一種であるミコバクテリウム・
スメグマテイスIFO3153(ヒトに病原性はない)
を、小川培地(燐酸二水素カリウム10g及びグル
タミン酸ナトリウム10gを蒸留水に溶解して1
とし、100℃で30分間滅菌する。この溶液100mlに
グリセリン6ml、2%マラカイトグリーン溶液6
ml及び全卵200mlを加えて混合し、ガーゼで過
したのち分注して血清凝固器内に斜面とし、第1
日は85℃で40分間、第2日及び第3日は80℃で40
分間滅菌後使用する)を用いて37℃で5分間培養
し、5日目に増殖した菌を白金耳でかき取り、め
のうの乳鉢中で滅菌生理食塩水に菌数が7.0×107
個/mlになるように懸濁(調製後同培地に平板培
養して測定)した。この菌液を接種菌液として用
いた。
各種消毒剤の所定量をデユボス液体培地2ml中
に加え、前記の菌液を注射器で2滴(約0.013ml)
ずつ滴下し、よく混合したのち37℃で5日間培養
し、ミコバクテリウム・スメグマテイスに対する
各種消毒剤の最小発育阻止濃度を測定した。
消毒剤としては、式の化合物の塩酸塩(分子
量900〜1100)のほか、比較のため塩化ベンザル
コニウム、クレゾール石けん液(日本薬局方)、
ヨードホール(有効沃素1.75%、非イオン系活性
剤11%含有製剤)及びメチルドデシルベンジルト
リメチルアンモニウムクロライド製剤
(MDBTC製剤と略す)を用いた。試験結果を第
1表に示す。
デユボス液体培地:燐酸二水素カリウム1.3g、
燐酸−水素ナトリウム2.2g、アスパラギン2g、
ペプトン5.2g、硫酸マグネシウム0.1g、クエン
酸鉄アンモニウム0.01g、硫酸亜鉛0.0001g、硫
酸銅0.0001g、塩化カルシウム0.0005g、マラカ
イトグリーン0.002g及びポリオキシエチレンソ
ルビタンモノオレエート0.5gを蒸留水に溶かし
て1とした液900mlをとり、121℃で15分間滅菌
する。これにグセリン5g、ぶどう糖7.5g、食
塩0.9g及びウシアルブミン5gを滅菌蒸留水に
溶かした溶液100mlを加え混和し調製する。
The present invention relates to a method for suppressing infectious diseases in livestock animals. Recently, there have been frequent outbreaks of mycobacterial infections in pigs in various places, and this is becoming a public health problem. The causative bacteria of mycobacterial disease in pigs are atypical mycobacteria such as Mycobacterium smegmatis and Mycobacterium intracellulare. Infection with these bacteria forms lesions similar to tuberculosis, resulting in so-called atypical anti-acid bacteria. Acidobacterosis occurs.
Because the disease of atypical mycobacterial disease is slow, it is difficult to recognize any abnormality in general clinical symptoms, and the only thing that can be seen is slightly poor growth, and in most cases, it is only discovered during slaughterhouse inspection. The lesions of this disease are generally localized to lymph nodes in the head and neck and mesentery, and vary from yellowish gray-white caseating lesions several millimeters in diameter to cases in which the entire lymph node is swollen. There are no known vaccines or drugs that are effective in preventing or treating this disease. Therefore, infected pigs should be detected as soon as possible using the tuberculin test and isolated from other pigs.
The only countermeasure is to thoroughly clean and wash the pigpen with water and then disinfect it. However, it is said that no matter what disinfectant is used, it cannot be completely sterilized. The present inventors have demonstrated that polyhexamethylene biganadine or its salts are effective against Mycobacterium smegmatis and Mycobacterium smegmatis, which are the causative bacteria of this disease.
It has been found that it has an excellent bactericidal effect against intracellulare and, unlike other disinfectants, maintains strong bactericidal activity even in the presence of organic matter such as chicken manure. Furthermore, in chickens, for example, chick dysentery, respiratory diseases, and coliosis occur frequently. The causative bacteria of these infectious diseases include Salmonella prolum, Salmonella teifimirium, Haemophilus gallinarum, Mycoplasma synobiae, and pathogenic Escherichia coli. Furthermore, in cases of mastitis in cows or infectious diseases in pigs and chickens, healing may be delayed or infections may occur due to the colonization of Pseudomonas aeruginosa due to bacterial alternation. In recent years, anthrax infections in cattle and pigs have also become a problem. As a result of the inventors' research on these,
The above-mentioned polyhexamethylene biganadine or its salt is applied to the above-mentioned bacteria by sensitizing it for 10-15 minutes to
It was found that it exhibits bactericidal activity at a dilution of 16,000 times, and that its bactericidal activity against Escherichia coli and other bacteria does not decrease significantly even in the presence of chicken manure. As a result of research into methods of disinfecting poultry houses, equipment, equipment, etc. using this compound, the present invention was achieved. The present invention is based on the formula (In the formula, n is a number indicating the degree of polymerization corresponding to a molecular weight of 700 to 1300) This is a method for controlling infectious diseases in livestock animals, which is characterized by spraying, dispersing, or washing the animals. Compounds of formula are described in U.S. Pat.
It is known from the various specifications of No. 3428576, and is known to exhibit antibacterial activity against general bacteria. According to Japanese Patent Publication No. 55-42611, it is also known to be effective against Clostridium botulinum. However, it exhibits excellent bactericidal activity against acid-fast bacteria such as Mycobacterium smegmatis, Salmonella prolum, Salmonella teifimirium, Haemophilus carinarum, Mycoplasma synobiae, pathogenic Escherichia coli, and Bacillus anthracis. Even in the presence of organic matter such as chicken feces or blood, the bactericidal activity against Mycobacterium smegmatis and pathogenic Escherichia coli does not decrease significantly, and this can be used to eliminate infectious diseases in livestock animals by spraying, spraying, or washing. It is a new finding by the present inventors that this can be effectively suppressed. On the other hand, other disinfectants such as chlorine, iodine compounds, and antibacterial soaps are hardly effective against Mycobacterium smegmatis and the like because their activity is significantly reduced by the presence of organic substances as described above. When carrying out the present invention, the compound of the formula or its salt is sprayed or sprinkled on poultry houses, equipment, equipment, etc., or washed with the same. This makes it possible to sterilize pathogenic bacteria in the house, in manure and on the body surfaces of livestock animals. The molecular weight of the compound of formula is 700-1300, preferably 900-1100. Inorganic acid salts such as hydrohalides, sulfates, nitrates or organic acid salts such as lactates, tartrates, succinates, maleates, malonates, gluconates of compounds of formula Since it is relatively soluble in organic solvents, it can be used in the form of a solution for spraying, spraying, or cleaning.
Moreover, instead of a solution, it may be made into a fine powder and sprayed or dispersed together with a suitable powder diluent. The concentration of the compound of formula or its salt in solution or fine powder is
0.01-10% by weight, preferably 0.03-5% by weight. The daily usage amount of the compound of formula or its salt is, for example, 10 to 1000 mg per pig, preferably 30 mg per pig.
~800mg, 1~100mg per chicken, preferably 3~
80mg, 0.1-10g per cow, preferably 0.3-8
It is g. Spraying or spraying or washing with this is usually done once to 10 times a day, every day during the breeding period of livestock animals. In that case, it is preferable to allow the fine particles (about 0.1 to 60 microns) of the drug to stay in the indoor space for about 30 seconds to 30 minutes each time. Experimental example 1 Mycobacterium, a type of atypical mycobacteria
Smegmatis IFO3153 (not pathogenic to humans)
and Ogawa medium (10 g of potassium dihydrogen phosphate and 10 g of sodium glutamate dissolved in distilled water.
and sterilize at 100℃ for 30 minutes. 100ml of this solution, 6ml of glycerin, 6ml of 2% malachite green solution
ml and 200 ml of whole eggs, mix, pass through gauze, dispense, make a slope in a serum coagulator, and place in the first
85℃ for 40 minutes on the second day and 40 minutes at 80℃ on the second and third days.
After sterilizing for 5 minutes before use), the bacteria were incubated at 37℃ for 5 minutes, and on the 5th day, the proliferated bacteria were scraped off with a platinum loop, and the number of bacteria was 7.0 x 10 7 in sterilized physiological saline in an agate mortar.
cells/ml (measured by plating on the same medium after preparation). This bacterial solution was used as an inoculum solution. Add the specified amount of various disinfectants to 2 ml of Dubos liquid medium, and add 2 drops (approximately 0.013 ml) of the above bacterial solution with a syringe.
The disinfectants were added dropwise, mixed well, and cultured at 37°C for 5 days, and the minimum inhibitory concentration of each disinfectant against Mycobacterium smegmatis was measured. As disinfectants, in addition to the hydrochloride of the compound of the formula (molecular weight 900 to 1100), for comparison, benzalkonium chloride, cresol soap solution (Japanese Pharmacopoeia),
Iodophor (preparation containing 1.75% available iodine and 11% nonionic active agent) and methyldodecylbenzyltrimethylammonium chloride preparation (abbreviated as MDBTC preparation) were used. The test results are shown in Table 1. Dubos liquid medium: 1.3 g of potassium dihydrogen phosphate,
Sodium hydrogen phosphate 2.2g, asparagine 2g,
Dissolve 5.2 g of peptone, 0.1 g of magnesium sulfate, 0.01 g of iron ammonium citrate, 0.0001 g of zinc sulfate, 0.0001 g of copper sulfate, 0.0005 g of calcium chloride, 0.002 g of malachite green, and 0.5 g of polyoxyethylene sorbitan monooleate in distilled water. Take 900 ml of the solution prepared in step 1 and sterilize it at 121℃ for 15 minutes. To this, 100 ml of a solution of 5 g of glycerin, 7.5 g of glucose, 0.9 g of common salt, and 5 g of bovine albumin dissolved in sterile distilled water is added and mixed.
【表】
この結果から、式の化合物の塩酸塩はミコバ
クテリウム・スメグマテイスに対し、他の消毒剤
に比してきわめて優れた抗菌力を示すことが認め
られる。
実験例 2
実験例1の方法で小川培地で培養したミコバク
テリウム・スメグマテイスを菌数1.9×108/mlに
なるよう滅菌生理食塩水に懸濁した菌液を接種菌
液とし、各種消毒剤にこの菌に対する殺菌効果を
測定した。消毒剤としては、式の化合物の塩酸
塩(分子量900〜1100)、比較薬剤として塩化ベン
ザルコニウム・クレゾール石けん液(日本薬局
方)、ヨードホール(有効塩素1.75%、非イオン
界面活性剤11%含有製剤)及びフエノールを用い
た。
消毒剤を滅菌蒸留水を用いて2倍段階希釈によ
り希釈し、5〜6段階の希釈液を調製し、それぞ
れ10mlずつを滅菌試験管に分注し、20℃の水浴中
に10分間静置した。これら薬剤希釈液にあらかじ
め準備した菌液を0.1mlづつ接種し、よく撹拌し
たのち再び20℃の水浴中に静置した。菌液を接種
してから25分、5分、10分及び15分(各感作時
間)後に、菌液接種の各薬剤希釈液を滅菌ピペツ
トでそれぞれ0.1mlずつ採取し、小川培地の表面
に滴下した。次いで37℃で5日間培養し、菌の発
育の有無により各消毒剤のミコバクテリウム・ス
メグマテイスに対する殺菌効果を調べた。式の
化合物についての希釈試験結果を第2表に、また
各種消毒剤を比較して、各感作時間における菌の
増殖を抑制した最高希釈倍数を第3表に示す。[Table] From these results, it is recognized that the hydrochloride of the compound of the formula exhibits extremely superior antibacterial activity against Mycobacterium smegmatis compared to other disinfectants. Experimental Example 2 A bacterial solution prepared by suspending Mycobacterium smegmatis cultured in Ogawa medium using the method of Experimental Example 1 in sterile physiological saline to a bacterial count of 1.9 x 10 8 /ml was used as the inoculum solution, and various disinfectants were used. The bactericidal effect against this bacterium was measured. As a disinfectant, the hydrochloride of the compound of formula (molecular weight 900-1100), benzalkonium chloride cresol soap solution (Japanese Pharmacopoeia) as a comparative agent, iodophor (available chlorine 1.75%, nonionic surfactant 11%) (containing formulations) and phenols were used. Dilute the disinfectant by 2-fold serial dilution using sterile distilled water to prepare 5 to 6 dilutions, dispense 10 ml of each into sterile test tubes, and leave them in a 20°C water bath for 10 minutes. did. Each of these drug dilutions was inoculated with 0.1 ml of the previously prepared bacterial solution, stirred thoroughly, and then placed in a water bath at 20°C again. 25 minutes, 5 minutes, 10 minutes, and 15 minutes (each sensitization time) after inoculating the bacterial solution, collect 0.1 ml of each diluted drug solution from the bacterial solution inoculation with a sterile pipette, and apply it to the surface of Ogawa medium. dripped. The samples were then cultured at 37°C for 5 days, and the bactericidal effect of each disinfectant against Mycobacterium smegmatis was examined based on the presence or absence of bacterial growth. Table 2 shows the dilution test results for the compound of the formula, and Table 3 shows the highest dilution factor that inhibited bacterial growth at each sensitization time by comparing various disinfectants.
【表】
を示す。
[Table] is shown below.
【表】
希釈倍数を示す。
15分間薬剤と感作した場合、菌の増殖を抑制し
た最高希釈倍数は、式の化合物の塩酸塩が8000
倍、ヨードホールが1600倍、塩化ベンザルコニウ
ムが400倍、クレゾール石けん液が160倍、フエノ
ールが80倍であつた。参考までにミコバクテリウ
ム・スメグマテイスに対する各種消毒剤のフエノ
ール係数を求めると、式の化合物の塩酸塩は
100、ヨードホールは17.5、塩化ベンザルコニウ
ムは7.5、クレゾール石けん液は3であつた。し
たがつて、式の化合物の塩酸塩は、非定型抗酸
菌であるミコバクテリウム・スメグマテイスに対
し、他の消毒剤にみられない優れた殺菌効果を示
すことが明らかである。
実験例 3
滅菌試験管に鶏糞(窒素量2.9%、水分10.8%)
を10%の割合に希釈した蒸留水4.9mlを入れ、こ
れに実験例1で得た菌液0.1mlを加え、充分に混
和して5mlとする。別に実験例2で用いた各消毒
剤を各測定希釈倍数の1/2の倍数に希釈した液各
5mlを前記の鶏糞液に加える。両液を合わせて
2.5分、5分、10分、15分及び30分(各感作時間)
後に、それぞれから0.1mlずつ採取し、新しい1
%小川培地に培養する。37℃で5日間培養したの
ち、増殖したミコバクテリウム・スメグマテイス
のコロニー数により各消毒剤の効果を判定した。
その結果を第4表に示す。[Table] Shows dilution factors.
When sensitized with the drug for 15 minutes, the highest dilution that inhibited bacterial growth was 8000 for the hydrochloride of the compound of formula
1,600 times more iodophor, 400 times more benzalkonium chloride, 160 times more cresol soap, and 80 times more phenol. For reference, when calculating the phenol coefficient of various disinfectants against Mycobacterium smegmatis, the hydrochloride of the compound of the formula is
100, iodophor was 17.5, benzalkonium chloride was 7.5, and cresol soap was 3. Therefore, it is clear that the hydrochloride of the compound of the formula exhibits an excellent bactericidal effect against Mycobacterium smegmatis, an atypical acid-fast bacterium, which is not seen in other disinfectants. Experimental example 3 Chicken manure in a sterile test tube (nitrogen content 2.9%, moisture 10.8%)
Add 4.9 ml of distilled water diluted to 10%, add 0.1 ml of the bacterial solution obtained in Experimental Example 1, and mix thoroughly to make 5 ml. Separately, 5 ml of each disinfectant used in Experimental Example 2 was diluted to 1/2 of the dilution ratio measured, and added to the chicken manure solution. Combine both liquids
2.5 minutes, 5 minutes, 10 minutes, 15 minutes and 30 minutes (each sensitization time)
After that, collect 0.1ml from each and add a new one.
% Ogawa medium. After culturing at 37°C for 5 days, the effectiveness of each disinfectant was determined based on the number of Mycobacterium smegmatis colonies that grew.
The results are shown in Table 4.
【表】【table】
【表】
鶏糞5%の存在下で式の化合物の塩酸塩は
1000倍希釈、5分以上の感作で殺菌効果を示した
が、塩化ベンザルコニウムは100倍希釈で30分以
上、50倍希釈で10分以上の感作時間が必要であつ
た。クレゾール石けん液は160倍希釈で15分以上、
80倍希釈で5分以上の感作時間を要した。またヨ
ードホールは10倍希釈で殺菌効果を示したが、25
倍以上の希釈では無効であり、ヨードの色がすべ
て消失していた。フエノールは40倍希釈で完全に
殺菌効果を示すが、80倍希釈では15分の感作時間
を要した。参考までに鶏糞5%の存在下における
各種消毒剤のミコバクテリウム・スメグマテイス
に対するフエノール係数を求めると、式の化合
物の塩酸塩は25、塩化ベンザルコニウムは1.3、
クレゾール石けん液は2、ヨードホールは0.29で
あり、本発明の殺菌剤はこのような条件下でもき
わめて優れた殺菌効果を有することが認められ
た。
実験例 4
各消毒薬を蒸留水で2倍段階希釈により求める
倍数に希釈し(フエノールは50〜100倍の10倍増
加希釈)、各希釈液10ml中にハートインフユージ
ヨンブイヨンで培養したサルモネラ・プログラム
中勇及び緑膿菌347の菌液、ならびに炭疸菌34F2
の芽胞液を、各1ml入れて混和する。接種菌液の
菌数はそれぞれ3.9×108/ml、1.3×108/ml及び
7.5×108/mlであつた。次いで0.5分、2.5分、5
分、10分及び15分(各感作時間)後に作用試験管
内の液を1白金耳新しいハートインフユージヨン
ブイヨン10mlに移植する。なお感作温度は20℃で
ある。37℃で48時間培養後、菌の発育の有無で各
消毒薬のサルモネラ・プロラム・緑膿菌347及び
炭疸菌34F2の芽胞に対する殺菌効果を調べた。
サルモネラ・プロラムに対する各種消毒剤の各感
作時間における有効希釈倍数を第5表に示す。
10分又は15分間薬剤と感作した場合、菌の増殖
を抑制した最高希釈倍数は、式の化合物の塩酸
塩が5000倍、ヨードホールが250倍、塩化ベンザ
ルコニウムが5000倍、MDBTC製剤が1000倍、
クレゾール石けん液が100倍、フエノールが80倍
であつた。参考までにサルモネラ・プロラムに対
する各種消毒剤のフエノール係数を求めると、式
の化合物の塩酸塩は59、ヨードホールは4.4、
塩化ベンザルコニウムは59、MDBTC製剤は
17.6、クレゾール石けん液は1.2であつた。した
がつて式の化合物の塩酸塩は、サルモネラ・プ
ロラムに対し、優れた殺菌作用を示すことが明ら
かである。[Table] In the presence of 5% chicken manure, the hydrochloride of the compound of formula is
A sensitization time of 5 minutes or more at a 1000-fold dilution showed a bactericidal effect, but benzalkonium chloride required a sensitization time of 30 minutes or more for a 100-fold dilution and 10 minutes or more for a 50-fold dilution. Cresol soap solution is diluted 160 times for 15 minutes or more.
The sensitization time required for 80-fold dilution was more than 5 minutes. Also, iodophor showed bactericidal effect when diluted 10 times, but 25
It was ineffective when diluted more than twice as much, and all the color of iodine disappeared. Phenol showed a complete bactericidal effect when diluted 40 times, but 15 minutes of sensitization time was required when diluted 80 times. For reference, when calculating the phenol coefficient of various disinfectants against Mycobacterium smegmatis in the presence of 5% chicken manure, the hydrochloride of the compound of the formula is 25, benzalkonium chloride is 1.3,
The value was 2 for cresol soap and 0.29 for iodophor, and it was confirmed that the disinfectant of the present invention has an extremely excellent disinfectant effect even under these conditions. Experimental Example 4 Each disinfectant was diluted with distilled water to the required number by 2-fold serial dilution (phenol was diluted in 10-fold increments from 50 to 100 times), and 10 ml of each diluted solution was incubated with Salmonella spp. cultured in heart infusion broth. Bacterial fluids of Program Nakayoshi and Pseudomonas aeruginosa 347, and Bacillus anthracis 34F 2
Add 1 ml of each spore solution and mix. The number of bacteria in the inoculated bacterial solution was 3.9×10 8 /ml, 1.3× 10 8 /ml, and
It was 7.5×10 8 /ml. Then 0.5 minutes, 2.5 minutes, 5
After 1, 10 and 15 minutes (each sensitization time), transfer one loop of the fluid in the working test tube into a fresh 10 ml heart infusion broth. The sensitization temperature was 20°C. After culturing at 37°C for 48 hours, the bactericidal effect of each disinfectant on Salmonella prorum, Pseudomonas aeruginosa 347, and Bacillus anthracis 34F 2 spores was examined based on the presence or absence of bacterial growth.
Table 5 shows the effective dilution factors for each sensitization time of various disinfectants against Salmonella prolumum. When sensitized with the drug for 10 or 15 minutes, the highest dilution that inhibited bacterial growth was 5000 times for the hydrochloride of the compound of formula, 250 times for iodophor, 5000 times for benzalkonium chloride, and 5000 times for MDBTC preparation. 1000 times,
The cresol soap solution was 100 times more concentrated, and the phenol was 80 times more concentrated. For reference, the phenol coefficients of various disinfectants against Salmonella prorum are 59 for the hydrochloride of the compound of formula, 4.4 for iodophor,
Benzalkonium chloride is 59, MDBTC preparation is
17.6, cresol soap liquid 1.2. It is therefore clear that the hydrochloride of the compound of the formula exhibits excellent bactericidal activity against Salmonella prolumum.
【表】【table】
【表】
また緑膿菌に対する各種消毒剤の殺菌効果を第
6表に示す。15分間薬剤と感作した場合、菌の増
殖を抑制した最高希釈倍数は、式の化合物の塩
酸塩が16000倍、ヨードホールが200倍、塩化ベン
ザルコニウムが4000倍、MDBTC製剤が800倍、
クレゾール石けん液が100倍、フエノールが80倍
であつた。参考までに緑膿菌に対する各種消毒剤
のフエノール係数を求めると、式の化合物の塩
酸塩は100、ヨードホールは3.8、塩化ベンザルコ
ニウムは50、MDBTC製剤は7.5、クレゾール石
けん液は1.9であつた。[Table] Table 6 also shows the bactericidal effects of various disinfectants against Pseudomonas aeruginosa. When sensitized with the drug for 15 minutes, the highest dilution that inhibited bacterial growth was 16,000 times for the hydrochloride of the compound of the formula, 200 times for iodophor, 4,000 times for benzalkonium chloride, and 800 times for the MDBTC preparation.
The cresol soap solution was 100 times more concentrated, and the phenol was 80 times more concentrated. For reference, the phenol coefficients of various disinfectants against Pseudomonas aeruginosa are 100 for the hydrochloride of the compound in the formula, 3.8 for iodophor, 50 for benzalkonium chloride, 7.5 for MDBTC preparations, and 1.9 for cresol soap. Ta.
【表】
次に炭疸菌の芽胞に対する各種消毒剤の殺菌効
果を第7表に示す。15分間薬剤を感作した場合、
菌の増殖を抑制した最高希釈倍数は、式の化合
物の塩酸塩が8000倍、ヨードホールが50倍、塩化
ベンザルコニウムが1000倍、MDBTC製剤が100
倍、クレゾール石けん液が5倍以下であつた。芽
胞に有効であるが、水銀剤であるため畜産用途で
使用されていない昇汞は2000倍で菌の増殖を抑制
した。[Table] Next, Table 7 shows the bactericidal effects of various disinfectants against anthrax spores. If you sensitize the drug for 15 minutes,
The highest dilution that inhibited bacterial growth was 8000 times for the hydrochloride of the compound of formula, 50 times for iodophor, 1000 times for benzalkonium chloride, and 100 times for MDBTC preparation.
The cresol soap solution was 5 times or less. Although it is effective against spores, Shohei, which is not used for livestock production because it is a mercury agent, inhibited the growth of bacteria by a factor of 2,000.
【表】
実験例 5
滅菌試験管に鶏糞(窒素量2.9%、水分10.6%)
をそれぞれ2%及び10%の割合で含む蒸留水各5
mlをいれ、これに野外で分離し、ハートインフユ
ージヨンブイヨンで24時間培養した病原性大腸菌
の菌液1ml(菌数1.0×109/ml)をいれ混和す
る。別に前記鶏糞液の代りに蒸留水5mlを、前記
菌液1mlと混和した液を調製する。式の化合物
の塩酸塩(分子量900〜1100)を各測定希釈倍数
の1/2の倍数に希釈した液各5mlを前記の各液に
加える。次いで2.5分、5分、10分、15分及び30
分後に、それぞれから1白金耳とり、新しいハー
トインフユージヨンブイヨン10mlで培養する。37
℃で48時間培養後、菌の発育の有無で式の化合
物の塩酸塩の病原性大腸菌に対する殺菌効果を調
べた。その結果を第8表に示す。
式の化合物の塩酸塩は病原性大腸菌に対し、
感作時間2.5分で2000倍、5分で4000倍、30分で
8000倍までの希釈倍数で殺菌効果が認められた。
そして有機物として鶏糞が1%存在しても感作時
間10分で2000倍、30分で4000倍、鶏糞が5%存在
しても感作時間2.5分で1000倍、15分以上で2000
倍の希釈倍数で殺菌効果が認められた。[Table] Experimental example 5 Chicken manure in a sterile test tube (nitrogen content 2.9%, moisture 10.6%)
5 each of distilled water containing 2% and 10% of
1 ml of pathogenic Escherichia coli bacteria isolated in the field and cultured in heart infusion broth for 24 hours (bacterial count: 1.0 x 10 9 /ml) and mixed. Separately, a solution is prepared by mixing 5 ml of distilled water instead of the chicken manure solution with 1 ml of the bacterial solution. Add 5 ml of a solution obtained by diluting the hydrochloride salt of the compound of the formula (molecular weight 900 to 1100) to a multiple of 1/2 of each measurement dilution factor to each of the above solutions. Then 2.5 minutes, 5 minutes, 10 minutes, 15 minutes and 30 minutes
After 1 minute, remove one loopful from each and incubate in 10 ml of fresh heart infusion broth. 37
After culturing at ℃ for 48 hours, the bactericidal effect of the hydrochloride of the compound of formula against pathogenic Escherichia coli was examined based on the presence or absence of bacterial growth. The results are shown in Table 8. The hydrochloride salt of the compound of formula
Sensitization time: 2,000 times in 2.5 minutes, 4,000 times in 5 minutes, 30 minutes
A bactericidal effect was observed at dilutions up to 8000 times.
Even if chicken manure is present as an organic substance at 1%, the sensitization time is 2000 times greater for 10 minutes, and 4000 times greater for 30 minutes; even if chicken manure is present at 5%, the sensitization time is 1000 times greater for 2.5 minutes, and 2000 times greater for 15 minutes or more.
A bactericidal effect was observed at double dilution.
【表】
殖しなかつたことを示す。
実施例 1
抗菌酸に感染した親豚(ツベルクリン反応陽性
で、頭頚部のリンパ節に結節様の症状が見られ、
その部分からリンパ液を採取し、小川培地で培養
して調べ非定型抗酸菌を分離した)4頭を入手
し、2頭ずつ別の豚舎にいれ飼育した。
一方の豚舎は式の化合物の塩酸塩(分子量
900〜1100)0.1重量%溶液を1日4回、1回5分
間噴霧し、3日間消毒したのち、健康な幼若豚10
頭を共に豚舎に入れ、6ケ月間飼育した。飼育の
間前記の消毒を毎日行い、飼育者は前記の消毒用
消毒液で毎日手の消毒を行つた。噴霧液量は1日
当り1.9であり、豚一頭当り式の化合物の塩
酸塩の使用量は約160mg/日である。別の豚舎は
前記の消毒を3日間行つたのち、健康な幼若豚10
頭を共に豚舎にいれ、以後飼育者の手の消毒以外
は前記の消毒を行うことなく、6ケ月間飼育し
た。
飼育終了後成育した豚をすべて屠殺し、解剖し
て結核様病巣の有無を調べた。その結果、消毒を
行わなかつた豚舎の成育豚10頭中4頭に腸間膜リ
ンパ節に結核様病巣が認められたのに対し、前記
の消毒を行つた豚舎の成育豚には全く病巣が認め
られず、順調な成育を示していた。
実施例 2
食用鶏各200羽ずつをそれぞれ別々の鶏舎にい
れ飼育した。一方の鶏舎は、式の化合物の塩酸
塩(分子量900〜1100)0.1重量%溶液であらかじ
め床を洗浄したのち、同じ溶液を1日2回、1回
5分間噴霧し、3日間消毒した。飼育の間前記の
消毒を毎日行い、飼育者は前記の消毒用溶液で毎
日手の消毒を行つた。噴霧液量は1日当り6.0
であり、鶏1羽当り式の化合物の塩酸塩の使用
量は約30mg/日である。別の鶏舎では飼育者の手
の消毒以外は以後前記の消毒を行うことなく、2
ケ月間飼育した。
飼育中に前記の消毒を行わなかつた鶏舎では30
羽が死亡した。そのうち19羽の肝臓、心臓又は脾
臓から病原性大腸菌が分離された。一方前記の消
毒を行つた鶏舎の鶏は17羽が死亡したが、解剖し
て調べても病原性大腸菌は検出されなかつた。
実施例 3
炭疸菌の感染によつておこる炭疸は、家畜法定
伝染病であり、保菌している家畜は発見しだいた
だちに殺処分しなければならない。そのため式
の化合物の塩酸塩は、炭疸菌の場合、家畜に対し
てよりも畜舎等の消毒効果に好適である。
炭疸菌の自然環境への散逸を防ぐため、感染室
内で畜舎に於ける実施例として、畜舎の壁を仮設
して次の実験を行つた。
感染室内に50cm×50cmのベニア板を垂直に立
て、これに25cm×25cmのアルミホイルをはりつけ
た。
このアルミホイルの中央部に1cm×10cmの短冊
形に切り取つた紙(東洋紙No.2)をセロテー
プではりつけ、これに炭疸菌34F2の芽胞を7.5×
107/mlの割合で含む水を0.1ml浸みこませた。少
し離れて別の短冊形の紙に炭疸菌34F2の芽胞
を7.5×107/mlの割合で含む5%牛糞液を0.1ml浸
みこませた。これら紙に式の化合物(塩酸
塩)の5000倍希釈液をベニヤ板全体に均一に噴霧
した。噴霧量は25mlになるよう調整した。
同様にヨードホルム、MDBTC製剤、塩化ベ
ンザルコニウム、クレゾール石けん液(局方)
各々100倍希釈液を噴霧した。
噴霧終了後ただちにハートインフユージヨンブ
イヨンに入れ、37℃で48時間培養した。その結果
を第9表に示す。[Table] Indicates that the species did not propagate.
Example 1 Parent pig infected with antibacterial acid (positive tuberculin test, nodule-like symptoms observed in lymph nodes in the head and neck,
Lymph fluid was collected from the area, cultured in Ogawa medium, and atypical acid-fast bacteria were isolated.) Four pigs were obtained, and two pigs were kept in separate pig pens. One pigpen is the hydrochloride of the compound of formula (molecular weight
900-1100) 0.1% by weight solution was sprayed 4 times a day for 5 minutes each time, and after disinfecting for 3 days, healthy young pigs 10
Both heads were placed in a pigpen and raised for 6 months. During breeding, the above-mentioned disinfection was carried out every day, and the caretakers disinfected their hands with the above-mentioned disinfectant every day. The amount of spray liquid is 1.9 per day, and the amount of hydrochloride of the formula compound per pig is approximately 160 mg/day. Another pigpen was disinfected as described above for 3 days, and then 10 healthy young pigs were found.
The heads of the pigs were placed together in a pig pen, and the pigs were raised for 6 months without any disinfection as described above, other than the hand disinfection of the handler. After rearing, all grown pigs were sacrificed and dissected to examine the presence or absence of tuberculosis-like lesions. As a result, tuberculosis-like lesions were found in the mesenteric lymph nodes in 4 out of 10 adult pigs in pigpens that had not been disinfected, whereas there were no lesions in adult pigs in pigpens that had been disinfected. It was not recognized and showed good growth. Example 2 200 meat chickens were kept in separate chicken houses. In one chicken house, the floor was cleaned in advance with a 0.1% by weight solution of hydrochloride of the compound of the formula (molecular weight 900-1100), and then the same solution was sprayed twice a day for 5 minutes each time to disinfect for 3 days. During breeding, the above-mentioned disinfection was carried out daily, and the caretakers disinfected their hands with the above-mentioned disinfectant solution every day. The amount of spray liquid is 6.0 per day.
The amount of the compound hydrochloride used per chicken is approximately 30 mg/day. In another poultry house, the above disinfection was not performed after that, except for the hand disinfection of the breeder.
It was kept for several months. 30 in poultry houses that did not carry out the above disinfection during breeding.
Feather died. Pathogenic E. coli was isolated from the liver, heart, or spleen of 19 of these birds. On the other hand, 17 chickens in the chicken house that had been disinfected as described above died, but no pathogenic E. coli was detected upon autopsy. Example 3 Anthrax caused by Bacillus anthracis infection is a legal infectious disease for domestic animals, and domestic animals carrying the disease must be killed as soon as they are discovered. Therefore, in the case of anthrax, the hydrochloride of the compound of the formula is more suitable for disinfecting livestock barns than for livestock. In order to prevent anthrax from dissipating into the natural environment, the following experiment was conducted in an infected room with the walls of a livestock barn temporarily installed. A 50 cm x 50 cm plywood board was placed vertically in the infection chamber, and a 25 cm x 25 cm piece of aluminum foil was attached to it. Attach a 1 cm x 10 cm strip of paper (Toyo Paper No. 2) to the center of this aluminum foil with sellotape, and add 7.5 x spores of Bacillus anthrax 34F2 to this.
0.1 ml of water containing 10 7 /ml was soaked. A short distance away, another strip of paper was soaked with 0.1 ml of a 5% cow feces solution containing 7.5 x 10 7 /ml of B. anthracis 34F 2 spores. A 5,000-fold diluted solution of the compound (hydrochloride) of the formula was sprayed onto these papers evenly over the entire plywood board. The amount of spray was adjusted to 25ml. Similarly, iodoform, MDBTC preparations, benzalkonium chloride, cresol soap liquid (pharmacopoeia)
A 100-fold dilution of each was sprayed. Immediately after spraying, the cells were placed in heart infusion broth and cultured at 37°C for 48 hours. The results are shown in Table 9.
【表】【table】
【表】
が増殖しなかつたことを示す。
式の化合物の塩酸塩は、5000倍の希釈倍数で
有効であり、しかも牛糞が存在していても効力に
影響を受けないことがわかる。[Table] shows that there was no proliferation.
It can be seen that the hydrochloride salt of the compound of the formula is effective at a dilution factor of 5000 times, and its efficacy is not affected even in the presence of cow dung.
Claims (1)
る重合度を示す数字である)で表されるポリヘキ
サメチレンバイガナジン又はその塩を含む薬剤を
用い、畜鶏舎及び/又はその器具、器材に対して
噴霧、散布もしくは洗浄することを特徴とする、
畜産動物の伝染性疾患の抑制方法。 2 畜産動物が豚、鶏又は牛であることを特徴と
する、特許請求の範囲第1項に記載の方法。[Claims] 1 formula (In the formula, n is a number indicating the degree of polymerization corresponding to a molecular weight of 700 to 1300) using a drug containing polyhexamethylene biganadine or its salt, poultry house and/or its equipment, characterized by spraying, dispersing or cleaning equipment;
Methods for controlling infectious diseases in livestock animals. 2. The method according to claim 1, wherein the livestock animal is a pig, chicken, or cow.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21063182A JPH0237882B2 (en) | 1982-12-02 | 1982-12-02 | CHIKUSANDOBUTSUNODENSENSEISHITSUKANNOYOKUSEIHOHO |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21063182A JPH0237882B2 (en) | 1982-12-02 | 1982-12-02 | CHIKUSANDOBUTSUNODENSENSEISHITSUKANNOYOKUSEIHOHO |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59101425A JPS59101425A (en) | 1984-06-12 |
| JPH0237882B2 true JPH0237882B2 (en) | 1990-08-28 |
Family
ID=16592514
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP21063182A Expired - Lifetime JPH0237882B2 (en) | 1982-12-02 | 1982-12-02 | CHIKUSANDOBUTSUNODENSENSEISHITSUKANNOYOKUSEIHOHO |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0237882B2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2544388B2 (en) * | 1986-09-04 | 1996-10-16 | 株式会社 上野製薬応用研究所 | Virus inactivating agent |
| KR100653007B1 (en) * | 2000-02-16 | 2006-11-30 | 주식회사 엘지생활건강 | Dandruff prevention and treatment composition |
| WO2006116778A2 (en) * | 2005-04-26 | 2006-11-02 | Douglas James Sutherland | Prophylactic materials |
| CN106719324B (en) * | 2016-11-22 | 2019-06-07 | 仁怀市黔北麻羊原种场 | A kind of cultural method improving the numb mutton quality in Guizhou Province north |
-
1982
- 1982-12-02 JP JP21063182A patent/JPH0237882B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPS59101425A (en) | 1984-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Saggers et al. | Polyvinyl-pyrrolidone-iodine: an assessment of antibacterial activity | |
| IE883856L (en) | Treatment of Mastitis and Applicator Therefor | |
| Snyder et al. | Alkaline glutaraldehyde, an effective disinfectant | |
| JP2020079290A (en) | Antimicrobial compositions and methods for their production | |
| US6630458B2 (en) | Teat dipping agent | |
| Tyski et al. | Animal Health Protection–Assessing Antimicrobial Activity of Veterinary Disinfectants and Antiseptics and Their Compliance with European Standards: A Narrative Review. | |
| Morton et al. | The bacteriostatic and bactericidal actions of some mercurial compounds on hemolytic streptococci: in vivo and in vitro studies | |
| JPH09110615A (en) | Disinfectant containing catechins | |
| JPS6345204A (en) | Germicidal composition | |
| JPH0237882B2 (en) | CHIKUSANDOBUTSUNODENSENSEISHITSUKANNOYOKUSEIHOHO | |
| Turabekov et al. | Enhancing animal welfare and immune health: a study on hydrogen peroxide and iodine-based disinfectants in farms | |
| CN102106347A (en) | Cinnamaldehyde, eugenol, thymol and tannin compound bactericide | |
| CN113016798A (en) | Low-temperature bactericide | |
| Williams | Formalin destruction of salmonellae in poultry litter | |
| RU2764178C1 (en) | Aqueous bactericidal composition for preventing and/or treating infectious diseases of hooves in animals and method for use thereof | |
| EP0354453B1 (en) | Antimicrobial agent for animals | |
| JP3624915B2 (en) | Disinfectant for barns and poultry houses | |
| Rahman et al. | Application of electrolyzed water on livestock | |
| RU2224544C1 (en) | Disinfectant | |
| JP2002187853A (en) | Disinfectiong agent for nipple of animal, and method for improving fungal environment | |
| JP2026050514A (en) | A method for reducing the risk of disease in livestock by contact with an aqueous solution containing a quaternary ammonium salt coupling agent, and a composition for reducing the risk of disease in livestock. | |
| Rahil et al. | COMPARATIVE STUDY OF VARIOUS DISINFECTANTS EFFICIENCY IN POULTRY FARMS | |
| JPH061719A (en) | Disinfecting and sterilizing agent for prevention of coccidiosis of animal | |
| Iakubchak et al. | SCIENTIFIC AND EXPERIMENTAL SUBSTANTIATION OF DEVELOPMENT AND APPLICATION OF DISINFECTANT OF COMBINED ACTION | |
| RU2403042C1 (en) | Medication possessing virulicidal, bactericidal and disinfecting action |